Guangdong's Study of the Effectiveness of China's Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
- PMID: 34594978
- PMCID: PMC8392787
- DOI: 10.46234/ccdcw2021.179
Guangdong's Study of the Effectiveness of China's Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
Keywords: Effectiveness; Inactivited COVID-19 Vaccine.
Conflict of interest statement
Conflicts of interestNo conflicts of interest were reported.
References
-
-
Kang M, Yi Y, Li Y, Sun LM, Deng AP, Hu T, et al. Effectiveness of inactivated COVID-19 vaccines against COVID-19 pneumonia and severe illness caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Guangdong, China. http://dx.doi.org/10.2139/ssrn.3895639. [2021-8-5].
-
-
-
World Health Organization. Tracking SARS-CoV-2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. [2021-8-12].
-
-
-
Share of the population fully vaccinated against COVID-19. OurWorldInData.org. https://ourworldindata.org/grapher/share-people-fully-vaccinated-covid. [2021-8-12].
-
LinkOut - more resources
Full Text Sources
Miscellaneous